NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$0.28
-0.02 (-7.90%)
Financial Highlights (FY 2026)
Revenue
64.75M
Net Income
135.34M
Gross Margin
20.2%
Profit Margin
209.0%
Rev Growth
—
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 64.75M 401.7K 362.7K 344.3K
Gross Profit 13.09M 254.9K 230.1K 218.5K
Operating Income 149.70M 60.1K 48.3K 45.7K
Net Income 135.34M 41.8K 46.7K 41.5K
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Rev Growth — +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 39.7K 153.4K 184.7K 169.1K
Total Equity 242.6K 435.1K 422.0K 475.1K
D/E Ratio 0.16 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 152.28M 62.8K 66.4K 61.5K
Free Cash Flow — 54.6K 52.4K 38.3K